BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27919972)

  • 1. Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.
    Toiyama Y; Shimura T; Yasuda H; Fujikawa H; Okita Y; Kobayashi M; Ohi M; Yoshiyama S; Hiro J; Araki T; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2016 Dec; 36(12):6491-6498. PubMed ID: 27919972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data.
    Xu BB; Lu J; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Sep; 22(5):1016-1028. PubMed ID: 30739259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
    Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
    J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the CRP-albumin ratio in patients with resectable pancreatic cancer.
    Arakawa Y; Miyazaki K; Yoshikawa M; Yamada S; Saito Y; Ikemoto T; Imura S; Morine Y; Shimada M
    J Med Invest; 2021; 68(3.4):244-255. PubMed ID: 34759138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
    Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
    In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent.
    Toiyama Y; Yasuda H; Ohi M; Yoshiyama S; Araki T; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Am J Surg; 2017 Jan; 213(1):120-126. PubMed ID: 27814784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer.
    Yamashita K; Ooki A; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
    Anticancer Res; 2008; 28(1B):435-41. PubMed ID: 18383882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
    Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
    J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
    Zhou W; Zhang GL
    PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
    Shimura T; Toiyama Y; Tanaka K; Saigusa S; Kitajima T; Kondo S; Okigami M; Yasuda H; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Anticancer Res; 2015 Sep; 35(9):4633-9. PubMed ID: 26254352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative NUn score serves as a robust predictor of overall and disease-specific survivals following radical surgery for gastric cancer.
    Urabe M; Okumura Y; Okamoto A; Yajima S; Yagi K; Yamashita H; Seto Y
    Langenbecks Arch Surg; 2024 Apr; 409(1):126. PubMed ID: 38619630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative C-reactive protein and operative blood loss predict poor prognosis in patients with gastric cancer after laparoscopy-assisted gastrectomy.
    Ishino Y; Saigusa S; Ohi M; Yasuda H; Tanaka K; Toiyama Y; Mohri Y; Kusunoki M
    Asian J Endosc Surg; 2014 Nov; 7(4):287-94. PubMed ID: 25123708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.